Top

BY Kellie Bramlet Blackburn

A team of researchers from across five disciplines at MD Anderson recently published the largest prospective study on breast implant associated anaplastic large cell lymphoma (BIA-ALCL), shedding light on the best treatment for patients with this uncommon cancer.

“This study underscores the critical importance of a standard treatment approach with a multi-team evaluation,” says Mark Clemens, M.D., the senior author of the study...

Mark Clemens, M.D., holds a silicone breast implant.

BY Kellie Bramlet Blackburn

MD Anderson surgeons have found a way to reduce pain and opioid use for lung cancer patients undergoing a lung...

BY Clayton Boldt, Ph.D.

The American Association for Cancer Research (AACR) is recognizing the founding members of The Cancer Genome Atlas (TCGA)&nbsp...

BY Clayton Boldt, Ph.D.

MD Anderson researchers have discovered that metastatic cancer cells in the brain upregulate expression of the EZH2 gene to activate a previously unknown pathway and recruit immune-suppressive neutrophils to the brain, allowing metastatic cells to thrive. The study, published in Science Translational Medicine, suggests that targeting this neutrophil recruitment may be a useful strategy for treating brain metastases.

“To gain...

Immunofluorescence showing infiltration of immunosuppressive neutrophils into brain metastases.

BY Jill Russell, Ph.D.

Researchers at MD Anderson have discovered that cancer-associated fibroblasts (CAF) help fuel the growth of breast tumors. Their findings...

BY Kelly Calagna

Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to holistic...

BY Kelly Calagna

Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting indicate...

BY Kelley Murfin

Findings from three studies led by researchers at MD Anderson suggest that new combination therapies are safe and effective against various...

BY Kelley Murfin

Two studies led by MD Anderson researchers explore advancements in CAR T cell therapy for non-Hodgkin lymphomas. CAR T cell therapy is commonly...

BY Meagan Raeke

Several MD Anderson-led studies at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting focus on using immunotherapy to provide...